Cefepime HCL 2 gram vials
Ended Awarded
- Contract number
- SPE2D325F199G
- Awardee
-
Sagent Pharmaceuticals, Inc. UEI PR1HCLM3FMW7
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $8,832
Award facts
- Contract value 100% obligated
- $8,832.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Schaumburg, IL 60173, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,832 firm fixed-price delivery order to Sagent Pharmaceuticals, Inc. for the supply of Cefepime HCL 2 gram vials. The contract, which was awarded on July 8, 2025, with an ultimate completion date of July 11, 2025, involves no set-aside designation, indicating the vendor competed on merit. Performance will take place at Sagent's facility in Schaumburg, Illinois. This delivery order falls under Sagent's existing single-award indefinite delivery/indefinite quantity contract with DLA Troop Support Medical, valued at approximately $29.6 million and running through March 3, 2031, which streamlines procurement of critical injectable medications for military treatment facilities and federal healthcare programs.
Sagent Pharmaceuticals is a specialty pharmaceutical manufacturer headquartered in Schaumburg, Illinois, specializing in injectable pharmaceutical products for federal agencies. The company maintains significant federal contract vehicles, including a $5.5 million Federal Supply Schedule contract with the Department of Veterans Affairs valid through April 30, 2029. Sagent's product portfolio for federal customers includes antibiotics, critical care medications, and anesthesia products, positioning the company as a key supplier of injectable pharmaceuticals to Defense and civilian medical institutions. The modest contract value reflects a routine supply delivery within the company's broader framework of supporting federal medical logistics requirements.
Quick answers
Who was awarded contract SPE2D325F199G?
SPE2D325F199G was awarded to Sagent Pharmaceuticals, Inc. by Medical Supply Chain (Troop Support) on July 8, 2025.
How much is contract SPE2D325F199G worth?
The government has obligated $8,832 on SPE2D325F199G.
Is contract SPE2D325F199G an order under another contract?
Yes. SPE2D325F199G is a delivery order under SPE2D021D0003, an indefinite delivery contract.
Was contract SPE2D325F199G competed?
The extent of competition for SPE2D325F199G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award